40 results on '"Radich, Jerald P"'
Search Results
2. Case Presentations: Allograft or Third-Line Therapy in Very Resistant CML
3. Treatment-Free Remission (TFR) Following Frontline Nilotinib in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP): 192-Weeks Data from the ENESTfreedom Study
4. Clinical Effect of Combined Mutations in DNMT3A, FLT3-ITD, and NPM1 Among Egyptian Acute Myeloid Leukemia Patients
5. ENESTfreedom 144-Week Update: Long-Term Treatment-Free Remission (TFR) Following Frontline Nilotinib in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
6. Recent advances in the genomics and therapy of BCR/ABL1 -positive and -negative chronic myeloproliferative neoplasms
7. Tyrosine Kinase Inhibitor Treatment for Newly Diagnosed Chronic Myeloid Leukemia
8. Next-Generation Sequencing in Adult B Cell Acute Lymphoblastic Leukemia Patients
9. Multigene Measurable Residual Disease Assessment Improves Acute Myeloid Leukemia Relapse Risk Stratification in Autologous Hematopoietic Cell Transplantation
10. Association between early promoter-specific DNA methylation changes and outcome in older acute myeloid leukemia patients
11. Allogeneic Hematopoietic Cell Transplantation for AML: is it Time to Move Toward a Minimal Residual Disease-Based Definition of Complete Remission?
12. Patients with Philadelphia-Positive Leukemia with BCR-ABL Kinase Mutations before Allogeneic Transplantation Predominantly Relapse with the Same Mutation
13. Janus Kinase Inhibitors and Allogeneic Stem Cell Transplantation for Myelofibrosis
14. Implications of BCR-ABL1 kinase domain-mediated resistance in chronic myeloid leukemia
15. IL-6 Controls Leukemic Multipotent Progenitor Cell Fate and Contributes to Chronic Myelogenous Leukemia Development
16. The Biology of Chronic Myelogenous Leukemia Progression: Who, What, Where, and Why?
17. P73. Regulation of myeloid leukemia by the cell fate determinant Musashi
18. Molecular Monitoring of Patients With Chronic Myeloid Leukemia: Clinical Examples From a Non-Trial Setting
19. Effect of Time to Major Molecular Response on Survival: Testing in Community Practice
20. Optimizing Timing of Secondary Tyrosine Kinase Therapy in Chronic Myeloid Leukemia
21. Monitoring Patients with Chronic Myeloid Leukemia Receiving Abl Tyrosine Kinase Inhibitor Therapy
22. Emerging Strategies in the Management of Chronic Myeloid Leukemia
23. Evidence of Donor-Derived Hematologic Malignancies after Hematopoietic Stem Cell Transplantation
24. Reduced Incidence of Acute and Chronic Graft-versus-Host Disease with the Addition of Thymoglobulin to a Targeted Busulfan/Cyclophosphamide Regimen
25. HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with chronic myeloid leukemia
26. Randomized trial of allogeneic related bone marrow transplantation versus peripheral blood stem cell transplantation for chronic myeloid leukemia
27. Fanconi anemia type C–deficient hematopoietic cells are resistant to TRAIL (TNF-related apoptosis-inducing ligand)-induced cleavage of pro-caspase-8
28. Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia
29. Individual-specific variation of gene expression in peripheral blood leukocytes
30. Single-stranded linear amplification protocol results in reproducible and reliable microarray data from nanogram amounts of starting RNA
31. Survival after second hematopoietic stem cell transplantation for recurrent pediatric acute myeloid leukemia
32. Molecular targets in acute myelogenous leukemia
33. Predictors of relapse and overall survival in Philadelphia chromosome[ndash ]positive acute lymphoblastic leukemia after transplantation
34. Predictors of relapse and overall survival in Philadelphia chromosome–positive acute lymphoblastic leukemia after transplantation
35. The promise of gene expression analysis in hematopoetic malignancies
36. Molecular measurement of minimal residual disease in Philadelphia-positive acute lymphoblastic leukaemia
37. Quantitative, real-time polymerase chain reactions for FLT3 internal tandem duplications are highly sensitive and specific
38. Philadelphia Chromosome–Positive Acute Lymphocytic Leukemia
39. Granulocyte colony-stimulating factor given to donors before apheresis does not prevent aplasia in patients treated with donor leukocyte infusion for recurrent chronic myeloid leukemia after bone marrow transplantation
40. Second allogeneic transplantation after failure of first autologous transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.